| Tresiba (insulin degludec) / Novo Nordisk |
ChiCTR1900026198: CN-TREAT (Chinese TREsiba AudiT) The effectof Tresiba (insulin degludec) in type 2 diabetes patients in real world clinical practice in China - a case records based retrospective study |
|
|
| Not yet recruiting | N/A | 938 | | Nil | Nanjing Drum Tower Hospital; Novo Nordisk A/S, Novo Nordisk A/S | type 2 diabetes | | | | |
ChiCTR2200056996: A randomized, open, two-period, self-cross-control design, using glucose clamp technology to evaluate pharmacodynamics and safety of insulin degludec injection |
|
|
| Not yet recruiting | N/A | 38 | | TR ;RT | The Second Affiliated Hospital of Xingtai Medical College; Zhuhai United Laboratories Co., Zhuhai United Laboratories Co. | For the treatment of adult type 2 diabetes | | | | |
ChiCTR2100049645: Effects of liraglutide combined with insulin degludec or intermittent fasting in type 2 diabetes mellitus and related mechanisms |
|
|
| Recruiting | N/A | 150 | | Liraglutide was combined with insulin deglume once daily ;Basal-prandial insulin ;5+2 light fasting ;Liraglutide injected subcutaneously once daily ;Oral metformin | Baoding First Central Hospital; Baoding First Central Hospital, none | Diabetes | | | | |
DE-CAF, NCT04671043: Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes |
|
|
| Completed | N/A | 21 | Europe | Caffeine and glucose, Glucose alone, Placebo | University Hospital Inselspital, Berne | Caffeine and Carbohydrate, Carbohydrate Only, Placebo | 02/23 | 02/23 | | |
DEAL-2, NCT06153537: A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level |
|
|
| Enrolling by invitation | N/A | 175 | RoW | Insulin degludec, Tresiba | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 01/25 | 03/25 | | |
NCT06178874: Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia |
|
|
| Completed | N/A | 90 | RoW | Insulin Glargine, Insulin Degludec, Insulin regular | Ain Shams University | Glycemic Control, Insulin, Critical Illness | 05/24 | 06/24 | | |
NCT06056167: Degludec Insulin Use in Critically Ill Patients |
|
|
| Completed | N/A | 155 | RoW | Degludec insulin | King Faisal Specialist Hospital & Research Center | Diabetes Mellitus, Critical Illness, Hyperglycemia | 05/24 | 05/24 | | |
CONNECT 1, NCT05069545: A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice |
|
|
| Enrolling by invitation | N/A | 227 | Europe | Insulin degludec, Fast-acting insulin aspart | Novo Nordisk A/S | Diabetes Mellitus, Type 1 | 09/24 | 09/24 | | |
CGM-DTx, NCT06111508: The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants. |
|
|
| Active, not recruiting | N/A | 30 | US | Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs, Degludec | University of Virginia, Novo Nordisk A/S | Type 2 Diabetes | 09/24 | 09/24 | | |
